Skip to content

A Physiological-Pathological Study of Sharira Kleda(body moisture) in context to Prameha (Type 2 Diabetes) and its management with Trishna Nigrahana Mahakashaya medicine

A Physio-Pathological Study of Sharira Kleda in context to Prameha (Type 2 Diabetes) and its management with Trishna Nigrahana Mahakashaya - Prameha, Type 2 Diabetes

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/026134
Enrollment
100
Registered
2020-06-25
Start date
Unknown
Completion date
Unknown
Last updated
2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

Intervention1: Trishna Nigrahana Mahakashaya Ghan Vati: Kalpana : Ghanavati Dose:500 mg Ghan Vati, 2 Vati BD Route of administration : Oral Time of administration

Sponsors

IPGT and RA GAU Jamnagar GujaratIPGT and RA GAU Jamnagar Gujarat
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having classical signs and symptoms of Prameha and Type ââ?¬â?? 2 Diabetes. Known patient of Type 2 Diabetes and also the preliminarily diagnosed patients on the basis of signs and symptoms of the disease are confirmed by FBS and PPBS. FBS ââ?°Â¥ 110 mg/dl to 250mg/dl and or PPBS level ââ?°Â¥ 200 mg/dl to 300mg/dl

Exclusion criteria

Exclusion criteria: 1) Patients age less than 18 year and more than 60 year. 2) Patients having FBS level less than 110 mg/dl or more than 250mg/dl and or PPBS level less than 200 mg/dl or more than 300mg/dl. 3) IDDM, Juvenile DM, Gestational DM 4) Prameha pidika (Diabetic nonhealing wound), Systemic infection, active infection other than superficial mild skin infestation. 5) Patients with severe complications like CVD, Nephropathy, Neuropathy, Retinopathy, Diabetic foot, fatal diabetic complication etc. 6)Patients of any other severe illness. 7)Other chronic debilitating diseases. 8)Pregnant woman.

Design outcomes

Primary

MeasureTime frame
Improvement will be assessed on the basis of relief found in cardinal symptoms of disease Progress in the sign and symptoms based on the slandered pattern will be applied before and after treatmentTimepoint: Improvement will be assessed after 30 days(after completion of study)

Secondary

MeasureTime frame
Improvement will be assessed on the basis of relief found in cardinal symptoms of disease Progress in the sign and symptoms based on the slandered pattern will be applied before and after treatmentTimepoint: Improvement will be assessed on 15th day of study

Countries

India

Contacts

Public ContactProf AS Baghel

INSTITUTUTE FOR POST GRADUAE AND TEACHING and RESEARCH IN AYURVEDA

asbaghel09@gmail.com9426433575

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026